why choose us

First received: July 14, 2023

Clinical Trial: Initiation of ARNi and SGLT2i in Patients With HFrEF

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Heart Failure With Reduced Ejection Fraction

Study Type: INTERVENTIONAL


Official Title: Initiation of Angiotensin Receptor-neprilysin Inhibitor (ARNi) and Sodium-glucose Cotransporter-2 Inhibitors (SGLT2i) in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF): the INITIAT

Brief Summary: Heart failure (HF) is a condition in which the heart does not contract ("pump") or relax well, leading to insufficient perfusion of vital organs.Ankle swelling, fatigue, and breathlessness are some of the features of this syndrome.There are different causes for HF (e.g., infarct and hypertension) and two distinct types: HFpEF - HF with preserved ejection fraction - the heart "pumps" but does not relax well and HFrEF/HFmrEF - HF with reduced or mildly reduced ejection fraction - where the…

Read more